Table 1 Comparison of patients, lesions, and procedural characteristics between the RA and the non-RA groups before and after propensity score matching using the match tolerance set as a width of 0.30 multiplied by the SD of the propensity score distribution.
Before propensity score matching | After propensity score matching | |||||||
---|---|---|---|---|---|---|---|---|
RA group (n = 203) | Non-RA group (n = 1147) | p value | Standardized difference | Matched RA group (n = 190) | Matched non-RA group (n = 190) | p value | Standardized difference | |
Patient characteristics | ||||||||
Age (years) | 74 (62.0–80.0) | 72 (64.0–77.0) | 0.001 | 0.331 | 74.0 (69.0–84.0) | 74.0 (69.0–84.0) | 0.952 | 0.010 |
Men—n, (%) | 145 (71.4) | 932 (81.3) | 0.002 | 0.235 | 138 (72.6) | 143 (75.3) | 0.640 | 0.062 |
Overweight (BMI ≥ 25 kg/m2)—n, (%) | 57 (28.1) | 414 (36.1) | 0.031 | 0.172 | 50 (26.3) | 50 (26.3) | 1.000 | 0 |
Hypertension—n, (%) | 186 (91.6) | 1024 (89.3) | 0.382 | 0.078 | 173 (91.1) | 172 (90.5) | 1.000 | 0.021 |
Diabetes mellitus—n, (%) | 112 (55.2) | 538 (46.9) | 0.030 | 0.167 | 103 (54.2) | 148 (77.9) | < 0.001 | 0.517 |
Insulin user—n, (%) | 36 (32.1) (n = 112) | 131 (24.3) (n = 538) | 0.096 | 0.174 | 32 (31.1) (n = 103) | 45 (30.4) (n = 148) | 1.000 | 0.015 |
Dyslipidemia—n, (%) | 178 (87.7) | 963 (84.0) | 0.206 | 0.106 | 165 (86.8) | 166 (87.4) | 1.000 | 0.018 |
Current smoker—n, (%) | 20 (10.4) (n = 192) | 200 (18.0) (n = 1111) | 0.009 | 0.219 | 20 (11.1) (n = 180) | 22 (12.0) (n = 184) | 0.870 | 0.028 |
Chronic renal failure (creatinine > 2 mg/dl)—n, (%) | 55 (27.1) | 129 (11.2) | < 0.001 | 0.413 | 46 (24.2) | 43 (22.6) | 0.809 | 0.038 |
Estimated GFR (mL/min/1.73 m2) | 53.5 (11.2–70.0) | 62.9 (47.6–77.8) | < 0.001 | 0.433 | 53.9 (22.43–71.0) | 53.1 (29.7–65.8) | 0.770 | 0.021 |
Chronic renal failure on hemodialysis—n, (%) | 53 (26.1) | 108 (9.4) | < 0.001 | 0.448 | 45 (23.7) | 34 (17.9) | 0.206 | 0.143 |
Statin treatment—n, (%) | 168 (82.8) | 871 (75.9) | 0.037 | 0.171 | 156 (82.9) | 159 (83.7) | 0.785 | 0.043 |
Lesion characteristics | ||||||||
Reason for PCI | 0.172 | 0.108 | 0.958 | 0.029 | ||||
PCI to the culprit of ST elevation myocardial infarction—n, (%) | 2 (1.0) | 5(0.4) | 2 (1.1) | 2 (1.1) | ||||
PCI to the culprit of non-ST elevation myocardial infarction—n, (%) | 32 (15.8) | 141 (12.3) | 29 (15.3) | 31 (16.3) | ||||
PCI to the non-AMI lesions—n, (%) | 169 (83.3) | 1001 (87.3) | 159 (83.7) | 157 (82.6) | ||||
Target lesion | < 0.001 | 0.948 | 0.103 | 0.137 | ||||
Left main–left anterior descending artery—n, (%) | 131 (64.5) | 502 (43.8) | 120 (63.2) | 105 (55.3) | ||||
Left circumflex artery—n, (%) | 18 (8.9) | 253 (22.1) | 18 (9.5) | 31 (16.3) | ||||
Right coronary artery—n, (%) | 54 (26.6) | 392 (34.2) | 52 (27.4) | 54 (28.4) | ||||
PCI to in-stent restenosis—n, (%) | 15 (7.4) | 125 (10.9) | 0.168 | 0.122 | 14 (7.4) | 22 (11.6) | 0.220 | 0.144 |
PCI to chronic total occlusion—n, (%) | 4 (2.0) | 120 (10.5) | < 0.001 | 0.357 | 4 (2.1) | 5 (2.6) | 1.000 | 0.033 |
Reference diameter (mm) | 2.39 (2.05–2.71) | 2.37 (2.00–2.83) | 0.853 | 0.012 | 2.38 (2.05–2.71) | 2.35 (2.04–2.69) | 0.714 | 0.042 |
Lesion length (mm) | 18.78 (11.52–35.02) | 14.84 (10.02–24.62) | < 0.001 | 0.301 | 17.79 (10.70–31.16) | 18.06 (11.21–26.99) | 0.513 | 0.111 |
Lesion angle | < 0.001 | 0.359 | 0.147 | 0.228 | ||||
Mild (< 45°) | 85 (41.9) | 665 (58.0) | 83 (43.7) | 88 (46.3) | ||||
Moderate (45°–90°) | 83 (40.9) | 375 (32.7) | 75 (39.5) | 83 (43.7) | ||||
Severe (> 90°) | 35 (17.2) | 107 (9.3) | 32 (16.8) | 19 (10.0) | ||||
Calcification | < 0.001 | 1.024 | 0.751 | 0.011 | ||||
None/mild, n (%) | 4 (2.0) | 864 (75.3) | 4 (2.1) | 6 (3.2) | ||||
Moderate/severe, n (%) | 199 (98.0) | 285 (24.8) | 186 (97.9) | 184 (96.8) | ||||
Bifurcation lesion (n = 585) | ||||||||
Medina classification | 0.097 | 0.578 | 0.544 | 1.248 | ||||
1,0,0 | 11 (8.3) (n = 132) | 48 (10.6) (n = 453) | 10 (8.4) (n = 119) | 9 (8.7) (n = 103) | ||||
1,0,1 | 7 (5.3) (n = 132) | 19 (4.2) (n = 453) | 7 (5.9) (n = 119) | 2 (1.9) (n = 103) | ||||
1,1,0 | 41 (31.1) (n = 132) | 124 (27.4) (n = 453) | 37 (31.1) (n = 119) | 36 (35.0) (n = 103) | ||||
1,1,1 | 18 (13.6) (n = 132) | 67 (14.8) (n = 453) | 17 (14.3) (n = 119) | 14 (13.6) (n = 103) | ||||
0,1,0 | 30 (22.7) (n = 132) | 107 (23.6) (n = 453) | 27 (22.7) (n = 119) | 21 (20.4) (n = 103) | ||||
0,1,1 | 23 (17.4) (n = 132) | 54 (11.9) (n = 453) | 19 (16.0) (n = 119) | 15 (14.6) (n = 103) | ||||
0,0,1 | 2 (1.5) (n = 132) | 34 (7.5) (n = 453) | 2 (1.7) (n = 119) | 6 (5.8) (n = 103) | ||||
Procedural characteristics | ||||||||
Successful PCI | 203 (100) | 1134 (98.9) | 0.237 | 0.149 | 190 (100) | 190 (100) | – | – |
Guiding catheter size | < 0.001 | 0.465 | < 0.001 | 0.688 | ||||
≤ 6Fr—n, (%) | 4 (2.0) | 638 (55.6) | 4 (2.1) | 76 (40.0) | ||||
7Fr—n, (%) | 180 (88.7) | 427 (37.2) | 167 (87.9) | 110 (57.9) | ||||
8Fr—n, (%) | 19 (9.4) | 82 (7.1) | 19 (10.0) | 4 (2.1) | ||||
Intra-aortic balloon pump support—n, (%) | 1 (0.5) | 10 (0.9) | 1.000 | 0.048 | 1 (0.5) | 4 (2.1) | 0.372 | 0.142 |
Use of orbital atherectomy—n, (%) | 0 (0) | 21 (1.8) | 0.060 | 0.191 | 0 (0) | 14 (7.4) | < 0.001 | 0.400 |
Use of scoring balloon or cutting balloon—n, (%) | 73 (36.0) | 301 (26.2) | 0.004 | 0.213 | 71 (37.4) | 86 (45.3) | 0.145 | 0.161 |
Side branch protection | < 0.001 | 0.259 | 0.137 | 0 | ||||
Jailed wire—n, (%) | 81 (39.9) | 262 (22.8) | 74 (38.9) | 54 (28.4) | ||||
Jailed corsair—n, (%) | 7 (3.4) | 32 (2.8) | 6 (3.2) | 7 (3.7) | ||||
Jailed balloon—n, (%) | 2 (1.0) | 8 (0.7) | 1 (0.5) | 1 (0.5) | ||||
Total stent and DCB length | 35.5 (20.0–48.5) (n = 202) | 24.0 (18.0–38.0) (n = 1117) | < 0.001 | 0.386 | 32.0 (20.0–46.5) (n = 189) | 30.0 (20.0–38.0) (n = 185) | 0.094 | 0.152 |
Kissing balloon technique—n, (%) | 0 (0) | 12 (1.0) | 0.232 | 0.142 | 0 (0) | 2 (1.1) | 0.499 | 0.149 |
Final PCI procedure | 0.082 | 0.632 | 0.220 | 0.424 | ||||
DES—n, (%) | 170 (83.7) | 936 (81.6) | 158 (83.2) | 153 (80.5) | ||||
DCB—n, (%) | 22 (10.8) | 155 (13.5) | 22 (11.6) | 25 (13.2) | ||||
DES + DCB—n, (%) | 8 (3.9) | 18 (1.6) | 7 (3.7) | 6 (3.2) | ||||
BMS—n, (%) | 2 (1.0) | 7 (0.6) | 2 (1.1) | 0 (0) | ||||
POBA—n, (%) | 1 (0.5) | 20 (1.7) | 1 (0.5) | 6 (3.2) | ||||
Other—n, (%) | 0 (0) | 11 (1.0) | 0 (0) | 0 (0) |